Dariohealth CORP 10-K annual reports

DarioHealth Corp. reported a decrease in 2025 revenues and continued net losses, alongside significant operational efficiency gains and customer growth, while initiating a strategic review to maximize shareholder value.

DarioHealth Corp. released its 10-K filing, summarizing its financial performance for the year ended December 31, 2024, and detailing its strategic initiatives for future growth in the digital health market.

DarioHealth Corp. has finalized a share exchange agreement and amended existing contracts, signaling a move to simplify its capital structure and enhance operational efficiency.